Ivabradine Improves All Aspects of Quality of Life Assessed with the 36-Item Short Form Health Survey in Subjects with Chronic Ischemic Heart Disease Compared with Beta-Blockers

By  

Pharmacology, Vol. 91, Iss. 1-2, 2012-11 ,pp. : 35-38

Karger

Access to resources Recommend Favorite

Fluorescent β-Blockers as Tools to Study Presynaptic Mechanisms of Neurosecretion

By Beltran Beatriz   Carrillo Romen   Martin Tomas   Martin Victor S.   Machado Jose D.   Borges Ricardo  

Pharmaceuticals, Vol. 4, Iss. 5, 2011-04 ,pp. : 713-725

MDPI

Access to resources Recommend Favorite

Beta-Blockers and Oxidative Stress in Patients with Heart Failure

By Nakamura Kazufumi   Murakami Masato   Miura Daiji   Yunoki Kei   Enko Kenki   Tanaka Masamichi   Saito Yukihiro   Nishii Nobuhiro   Miyoshi Toru   Yoshida Masashi   Oe Hiroki   Toh Norihisa   Nagase Satoshi   Kohno Kunihisa   Morita Hiroshi   Matsubara Hiromi   Kusano Kengo F   Ohe Tohru   Ito Hiroshi  

Pharmaceuticals, Vol. 4, Iss. 8, 2011-08 ,pp. : 1088-1100

MDPI

Access to resources Recommend Favorite

Ivabradine Prevents Heart Rate Acceleration in Patients with Chronic Obstructive Pulmonary Disease and Coronary Heart Disease after Salbutamol Inhalation

By Zulkarneev Rustem   Zagidullin Naufal   Abdrahmanova Guzel   Hoppe Uta C.   Zagidullin Shamil  

Pharmaceuticals, Vol. 5, Iss. 4, 2012-04 ,pp. : 398-404

MDPI

Access to resources Recommend Favorite

Antibiotic Treatment in End-of-Life Cancer Patients—A Retrospective Observational Study at a Palliative Care Center in Sweden

By Helde-Frankling Maria   Bergqvist Jenny   Bergman Peter   Björkhem-Bergman Linda  

Cancers, Vol. 8, Iss. 9, 2016-09 ,pp. : 84-84

MDPI

Access to resources Recommend Favorite